Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AHRQ Tech Assessment Supports Primary Prevention Implantable Defibrillators

This article was originally published in The Gray Sheet

Executive Summary

The agency affirms the evidence in favor of implantable defibrillators for primary prevention of sudden cardiac death is strong for patients with reduced left-ventricular ejection fraction, but does not support resynchronization ICDs for this population.

You may also be interested in...

Richard Kronick Appointed As Next AHRQ Director

Kronick moves to the head of the Agency for Healthcare Research and Quality, replacing Carolyn Clancy, after serving as deputy assistant secretary for planning and evaluation at HHS since January 2010.

CMS Issues List Of Potential National Coverage Determination Topics

Most of the 33 items or services in the list have implications for manufacturers of medical devices, combination products or diagnostics.

ICD Scrutiny: Study Quantifies Significant Off-Guideline Implant Activity

The implantable defibrillator sector took another potential hit last week with findings that more than 20% of patients treated with the devices for primary prevention of sudden cardiac death should not receive them under current guidelines.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts